| 期 | 标题 | 文件 | 
		| 卷 41, 编号 3 (2024) | Brain insulin resistance in neurological disorders of various genesis: current state and treatment approaches |  (Rus)
 | 
	| Zorina I., Shpakov A. | 
		| 卷 41, 编号 2 (2024) | N-Cadherin — A Potential Target for Psychopharmacology |  (Rus)
 | 
	| Firstova Y., Kovalev G. | 
		| 卷 41, 编号 1 (2024) | Promising markers of neuroinflammation in schizophrenia |  (Rus)
 | 
	| Sakharov A., Golygina S. | 
		| 卷 41, 编号 1 (2024) | Stress influences and cognitive activity: search for targets and general mechanisms using Drosophila mutants |  (Rus)
 | 
	| Karovetskaya D., Medvedeva A., Tokmacheva E., Vasilyeva S., Rebrova A., Nikitina E., Shchegolev B., Savvateeva-Popova E. | 
		| 卷 41, 编号 1 (2024) | Ciliary neurotrophic factor as a potential biomarker of cerebral pathologies |  (Rus)
 | 
	| Gudkova A. | 
		| 卷 40, 编号 4 (2023) | Multiple Mechanisms of the Therapeutic Effect of Trehalose in Inhibition of Experimental Neurodegeneration |  (Rus)
 | 
	| Pupyshev A., Korolenko T., Tikhonova M. | 
		| 卷 40, 编号 4 (2023) | Role of VEGF in Angiogenesis and Motor Recovery after Ischemic Stroke |  (Rus)
 | 
	| Kucherova K., Koroleva E., Alifirova V. | 
		| 卷 40, 编号 4 (2023) | Structural Determinants of Small Extracellular Vesicles (Exosomes) and Their Role in Biological Functions |  (Rus)
 | 
	| Tourchinets A., Yakovlev A. | 
		| 卷 40, 编号 4 (2023) | State-of-the-Art: the Use of Extracellular Vesicles and Preparations Based on Them for Neuroprotection and Stimulation of Brain Tissue Regeneration after Injury |  (Rus)
 | 
	| Basalova N., Dzhauari S., Yurshev Y., Primak A., Efimenko A., Tkachuk V., Karagyaur M. | 
		| 卷 40, 编号 4 (2023) | Anomalies of Energy Metabolism in Schizophrenia and Possible Pathogenetic-Targeted Therapeutic Approaches |  (Rus)
 | 
	| Boksha I., Prokhorova T., Savushkina O., Tereshkina E., Vorobyeva E., Burbaeva G. | 
		| 卷 40, 编号 4 (2023) | T-Cell Aspects of Some Neurological Diseases |  (Rus)
 | 
	| Kvichansky A., Bolshakov A. | 
		| 卷 40, 编号 4 (2023) | Some Advanced Biomarkers of Neurodegenerative Disorders: Focus on Cystatin C |  (Rus)
 | 
	| Korolenko T., Pupyshev A., Belichenko V., Tikhonova M., Amstislavskaya T. | 
		| 卷 40, 编号 3 (2023) | Metabolic Plasticity of a Developing and Aging Brain |  (Rus)
 | 
	| Salmina A. | 
		| 卷 40, 编号 3 (2023) | Markers of Neurodegeneration in Parkinson’s Disease |  (Rus)
 | 
	| Nikitina M., Alifirova V., Borodina S., Koroleva E. | 
		| 卷 40, 编号 2 (2023) | The Origins and Background of the Creation of the Nootropics Concept |  (Rus)
 | 
	| Shabanov P. | 
		| 卷 40, 编号 2 (2023) | Creation and Study of the Mechanism of Action of Compounds of a New Class of Positive Modulators of AMPA Receptors – Derivatives of 3,7-Diazabicyclo[3.3.1]nonanes |  (Rus)
 | 
	| Grigoriev V., Lavrov M., Palyulin V., Garibova T., Anokhin K., Bachurin S. | 
		| 卷 40, 编号 2 (2023) | Cognitive Impairment and Nootropic Drugs: Mechanism of Action and Spectrum of Effects |  (Rus)
 | 
	| Voronina T. | 
		| 卷 40, 编号 2 (2023) | Irisin at the Crossroad of Autophagy and BNDF Signaling for Neuroplasticity Regulation |  (Rus)
 | 
	| Andyarzhanova E., Voronina T. | 
		| 卷 40, 编号 2 (2023) | Neurodevelopmental Disorders in Children: Neuroplasticity and Possibilities of Nootropic Pharmacotherapy |  (Rus)
 | 
	| Zavadenko N. | 
		| 卷 40, 编号 1 (2023) | Neurospecific Proteins as Transdiagnostic Markers of Affective Disorders |  (Rus)
 | 
	| Levchuk L., Bokhan N., Ivanova S. | 
		| 卷 40, 编号 1 (2023) | Outlooks of Using Small Extracellular Vesicles as a Transport Vehicle through the Blood–Brain Barrier |  (Rus)
 | 
	| Khaspekov L., Yakovlev A. | 
		| 卷 40, 编号 1 (2023) | Biochemical Platelet Markers of Cognitive Impairment in Alzheimer’s Disease |  (Rus)
 | 
	| Kodintcev A., Izmozherova N., Popov A., Volkova L., Antropova I., Ryabinina A. | 
		| 卷 40, 编号 1 (2023) | Interleukin-6 Role in Schizophrenia Pathological Mechanisms |  (Rus)
 | 
	| Rukavishnikov G., Zhilyaeva T., Dubinina E., Mazo G. | 
	
		| 1 - 23 的 23 信息 |  |